Revolution Medicines D
D
RVMD
172.280
USD
-4.01
(-2.27%)
Post Trading·172.020USD-0.260(-0.15%)
Last updated: · Delayed 15 min
Revolution Medicines market capWhat is market capitalization? Market cap is what the stock market values a whole company at: its share price times the number of its shares outstanding.
Revolution Medicines's market cap is 37.26B USD: 216,292,000 shares outstanding at today's price of 172.28.
- Today
- 37.26B
- Average, 5 years
- 10.94B
- Low, 5 years
- 1.08B
- High, 5 years
- 46.66B
Market cap = price × shares outstanding = 172.28 × 216.29M = 37.26B
Each day's closing price times the shares outstanding in the last 10-Q or 10-K filed by then (the quarter's basic share count, adjusted for splits); from the latest count on, the shares outstanding now.
Market cap by year and by quarter
| Fiscal year | Period ending | Market cap |
|---|---|---|
| Today | 37.26B | |
| FY2025 | 31 Dec 2025 | 15.14B |
| FY2024 | 31 Dec 2024 | 7.34B |
| FY2023 | 31 Dec 2023 | 3.25B |
| FY2022 | 31 Dec 2022 | 1.92B |
| FY2021 | 31 Dec 2021 | 1.83B |
| FY2020 | 31 Dec 2020 | 2.64B |
| FY2019 | 31 Dec 2019 | 1.05B |
| FY2018 | 31 Dec 2018 | 1.05B |
| FY2017 | 31 Dec 2017 | 1.05B |
| Quarter | Period ending | Market cap |
|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 44.12B |
| Q2 FY2026 | 30 Jun 2026 | 39.50B |
| Q1 FY2026 | 31 Mar 2026 | 19.27B |
| Q4 FY2025 | 31 Dec 2025 | 15.14B |
| Q3 FY2025 | 30 Sept 2025 | 8.84B |
| Q2 FY2025 | 30 Jun 2025 | 6.92B |
| Q1 FY2025 | 31 Mar 2025 | 6.65B |
| Q4 FY2024 | 31 Dec 2024 | 7.34B |
| Q3 FY2024 | 30 Sept 2024 | 7.57B |
| Q2 FY2024 | 30 Jun 2024 | 6.41B |
| Q1 FY2024 | 31 Mar 2024 | 5.22B |
| Q4 FY2023 | 31 Dec 2023 | 4.05B |
| Q3 FY2023 | 30 Sept 2023 | 3.02B |
| Q2 FY2023 | 30 Jun 2023 | 2.86B |
| Q1 FY2023 | 31 Mar 2023 | 2.05B |
| Q4 FY2022 | 31 Dec 2022 | 2.12B |
| Q3 FY2022 | 30 Sept 2022 | 1.67B |
| Q2 FY2022 | 30 Jun 2022 | 1.45B |
| Q1 FY2022 | 31 Mar 2022 | 1.89B |
| Q4 FY2021 | 31 Dec 2021 | 1.86B |
| Q3 FY2021 | 30 Sept 2021 | 2.02B |
| Q2 FY2021 | 30 Jun 2021 | 2.33B |
| Q1 FY2021 | 31 Mar 2021 | 3.23B |
| Q4 FY2020 | 31 Dec 2020 | 2.63B |
| Q3 FY2020 | 30 Sept 2020 | 2.26B |
| Q2 FY2020 | 30 Jun 2020 | 1.85B |
| Q1 FY2020 | 31 Mar 2020 | 641.91M |
| Q4 FY2019 | 31 Dec 2019 | 1.05B |
| Q3 FY2019 | 30 Sept 2019 | 1.05B |
| Q2 FY2019 | 30 Jun 2019 | 1.05B |
| Q1 FY2019 | 31 Mar 2019 | 1.05B |
| Q4 FY2018 | 31 Dec 2018 | 1.05B |
See also:ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about Revolution Medicines's market cap
Source: Financial Modeling PrepVerified against SEC filings